This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives for weight loss include the injections Wegovy®, Mounjaro®, Zepbound®, ...

Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.

TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and ...

The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 ...

The deal offers popular weight loss drugs to be sold for as low as $149 on President Donald Trump's direct-to-consumer ...

The US president’s sudden policy reversal on weight-loss drugs like Ozempic and Wegovy could reshape the global market, from ...

Semaglutide, available under the brand names Ozempic, Wegovy, and the oral tablet Rybelsus, is effective for diabetes and weight management, but like any medication, it may have some side effects.

Shares of Novo Nordisk are down 2.5% on Friday after the Trump administration announced agreements with the Danish drugmaker and Eli Lilly to cut prices for GLP-1 drugs used to treat diabetes and ...